Philippines Dossier Language: English Submission and Certified Translation
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Yes, it is required. Philippine submissions must be in English, or in English together with Filipino. Non-English originals — Chinese test reports, quality system documents, instructions for use — must be accompanied by certified English translations. Compared with the English-only system in Singapore, the difference is that non-English originals still have to be translated, whereas Singapore accepts English originals and therefore needs no translation at all.
GRZAN note: the cost of translation is predictable and easy to budget; the risk it creates is not. Inconsistent terminology can make one component look like three different components across three modules, and no amount of correct grammar repairs that impression. The workstream can be remembered as 1 submission language, 1 glossary fixed before drafting starts, and 1 label red line that admits no exception.
- Submissions in English, with Filipino optional;
- Non-English originals accompanied by certified English translations;
- Labels in English; labels containing Chinese are not accepted;
- Sticker labelling permitted for supplementary local information on imports.
The sequencing point matters more than it appears. Terminology has to be settled before the first module is translated, because retrofitting a glossary across a finished dossier means reopening every document that used the old wording, and each reopening is a fresh opportunity for a version mismatch to enter the file. The same logic applies to the choice of translator: a single supplier working from a single glossary produces a more coherent file than several suppliers each working from their own understanding of the product.
2. Legal basis
The language requirement, the label rule and the authentication chain that applies to foreign-language originals are summarised below. The comparison row is included because the differences between neighbouring markets drive most scheduling decisions in a regional programme.
| Legal instrument | Department of Health Administrative Order No. 2018-0002 |
| Reference | AO No. 2018-0002, 26 January 2018 |
| Document template | CSDT, including the submission language requirement |
| Label language | English, with Filipino optional; labels containing Chinese are not accepted |
| Import supplement | Sticker labelling is permitted to add local information |
| Authentication chain | Foreign documents require notarisation plus Apostille (in force between China and the Philippines from 7 November 2023) |
| Comparison | Singapore: English only, no translation required and no notarisation or Apostille chain |
3. Expert insights
Insight 1: translation creates a consistency risk, not merely a cost. Translation itself is not difficult; terminological consistency is. Within a single Chinese technical document, several expressions may refer to the same component, and if those expressions are rendered as three different English terms in three different modules, a reviewer will reasonably conclude that three different objects are being described. The workable control is a project-level glossary that fixes the product name, model designation, component names and technical parameter names, with every translation following it. The glossary should be treated as a controlled document in its own right, versioned and dated, because a glossary that changes mid-project produces exactly the inconsistency it was created to prevent.
Insight 2: the required form of translation certification should be confirmed in advance. A certified English translation may in practice require a translator qualification statement, a translation agency stamp, or notarisation. Requirements can differ between document types and can change over time. It is prudent to confirm with the CDRRHR, before submission, which form of translation certification is currently accepted, so that the file is not returned for a reason that has nothing to do with its content. A single written confirmation at project start is sufficient to settle the question for the whole file.
Insight 3: label language is a hard line, and Chinese on a label leads to rejection. A label must carry the product name and model, the CMDN or CMDR registration number, the name and address of the manufacturer and of the local licence holder, the country of origin, the batch or serial number, the date of manufacture and the expiry date, the sterilisation status and method where applicable, storage conditions, warnings and precautions, and the intended use. Any Chinese on the label will cause the file to be returned. The remedy is sticker labelling: an English supplementary label applied over the original, carrying the locally required elements. Because the sticker becomes part of the approved labelling once accepted, its content has to be controlled to the same standard as the original artwork rather than treated as a warehouse task.
Insight 4: measured against its neighbours, the Philippine language workflow sits in the middle. Singapore is the lightest: English originals, no translation and no authentication chain. The Philippines sits in the middle: English submission, translation for non-English originals, and notarisation plus Apostille for foreign documents. Vietnam, Thailand and Indonesia are the heaviest: local-language submission, translation, and embassy legalisation for foreign documents. When planning across Southeast Asia, these differences in language and authentication workflow should be treated as scheduling variables rather than as administrative detail, because they determine how long each country file takes to assemble even when the underlying technical evidence is identical.
4. Practical recommendations
- Build a project glossary and fix terminology before translating. Prevent one object from acquiring several English names.
- Finalise labels at the submission stage. File an English label specimen so that later label changes are not required.
- Use sticker labelling for import-stage supplementary information. The added content must still match what was approved.
- Confirm the accepted form of translation certification with the CDRRHR in advance.
These four measures address the same failure from different directions: a dossier that is linguistically clean but terminologically unstable reads as inconsistent even when every individual sentence is correct. Fixing vocabulary at the start, labels at submission, sticker content at approval and certification form before filing keeps the language workstream from feeding defects into the technical one.
5. Verification checklist
- □ All documents in English, checked one by one
- □ Non-English originals accompanied by translations corresponding to the source
- □ Terminology consistent, checked against the project glossary
- □ Translation certification form confirmed against the current CDRRHR position
- □ Labels free of Chinese, verified on the specimen
- □ All ten label elements present, checked against the element list
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including the Philippines. Our team prepares CMDN/CMDR dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the FDA Philippines, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us